AKT2 and triple-negative breast carcinoma: By integrating tetrahedral DNA nanostructures with carbon nanotubes, the detection of ctDNA associated with AKT2 genes in triple-negative breast cancer has been achieved, and this platform also facilitates the identification of other biomarkers (116).